Kaspersky has today announced the opening of its new Transparency Center in Istanbul, Turkey, where the company’s stakeholders can learn more about Kaspersky solutions, review its source code or examine the results of independent audits. This marks further expansion of the company’s Global Transparency Initiative (GTI),Read More…

Moro Hub, a subsidiary of Digital DEWA, the digital arm of Dubai Electricity and Water Authority (PJSC) and Kaspersky, signed a Memorandum of Understanding (MoU) to facilitate collaboration in cybersecurity. The MoU was signed by Dr. Ahmed Alketbi CISO of DEWA & Moro Hub and Eugene Kaspersky, CEO of KasperskyRead More…

Kaspersky has presented an updated operating system for thin clients that offers enhanced connectivity, higher speed of applications delivery, lower total cost of ownership, user-friendly graphical interface and quick deployment. It is the main component of the Cyber Immune solution for building thin client infrastructure in a wide range ofRead More…

As the malware development market continues to flourish with new stealers, such as Lumma, for the last three years, Redline has remained the dominant data-stealing malware used by cybercriminals. Kaspersky Digital Footprint Intelligence finds that more than half of every device (55%) targeted by password-stealer attacks in 2023 has beenRead More…

Nearly 10 million devices fell victim to data-stealing malware in 2023, Kaspersky Digital Footprint Intelligence has revealed, drawing from insights gathered from infostealer malware log files traded on underground markets. With cybercriminals pilfering an average of 50.9 login credentials per infected device, the threat posed by data-stealers is growing forRead More…

Kaspersky experts have discovered a concerning trend with legitimate-looking phishing pages offering the famed weight-loss drug to consumers fighting the ‘battle of the bulge’. Diabetes medication Ozempic was found to have weight-loss and appetite-suppressing properties, prompting celebrities and, consequently, the public to buy the drug,Read More…